Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-Current Deferred Tax Liability (2016 - 2021)

Assembly Biosciences has reported Non-Current Deferred Tax Liability over the past 7 years, most recently at $2.5 million for Q3 2021.

  • Quarterly results put Non-Current Deferred Tax Liability at $2.5 million for Q3 2021, changed 0.0% from a year ago — trailing twelve months through Sep 2021 was $2.5 million (changed 0.0% YoY), and the annual figure for FY2020 was $2.5 million, changed 0.0%.
  • Non-Current Deferred Tax Liability for Q3 2021 was $2.5 million at Assembly Biosciences, roughly flat from $2.5 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for ASMB hit a ceiling of $3.3 million in Q4 2018 and a floor of $2.1 million in Q4 2017.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $2.5 million (2019), compared with a mean of $2.7 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: tumbled 80.79% in 2017 and later skyrocketed 52.25% in 2018.
  • Assembly Biosciences' Non-Current Deferred Tax Liability stood at $2.1 million in 2017, then skyrocketed by 52.25% to $3.3 million in 2018, then fell by 22.17% to $2.5 million in 2019, then changed by 0.0% to $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021.
  • The last three reported values for Non-Current Deferred Tax Liability were $2.5 million (Q3 2021), $2.5 million (Q2 2021), and $2.5 million (Q1 2021) per Business Quant data.